Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Cti Biopharma Corp changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 63 | 92 | +29 |
| Shares | 47.7M | 59.6M | +11.9M (+24.9%) |
| Value | $118.3M | $344.9M | +$226.5M (+191.4%) |
New holders (33)
Institutions that held Cti Biopharma Corp at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (4)
Institutions that held Cti Biopharma Corp at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Caxton Corp | 2,239,300 | $5.55M |
| TD Waterhouse Canada Inc. | 45 | $109 |
| First Manhattan Co | 33 | $0 |
| Concord Wealth Partners | 3 | $0 |